In a recent phase II trial, researchers further investigated the potential long-term benefits of aggressive local treatment in patients with unresectable colorectal liver metastases.
The first-and-only fully human monoclonal anti-epidermal growth factor receptor antibody for the treatment of wild-type RAS metastatic colorectal cancer was recently approved by the US Food and Drug...
Physicians reviewing patient-facing screening guidance from major cancer centers may encounter recommendations that do not fully align with USPSTF standards. In a cross-sectional analysis, investigators...
